The effect of murine anti-thymocyte globulin on experimental kidney warm ischemia-reperfusion injury in mice

Hye Ryoun Jang, Maria Teresa Gandolfo, Gang Jee Ko, Lorraine Racusen, Hamid Rabb

Research output: Contribution to journalArticle

15 Citations (Scopus)

Abstract

Kidney ischemia-reperfusion injury (IRI) is an important contributor to delayed graft function (DGF) and poor outcome of allografts. Small clinical studies suggest a beneficial role for human anti-thymocyte globulin (ATG) in DGF. We investigated the short-term effect of mouse anti-thymocyte globulin (mATG) on kidney warm IRI in mice. We administered either mATG, rabbit immunoglobulin (RIgG), or saline with different dosing schedules in three different IRI models: 30 min bilateral, 60 min bilateral, and 45 min unilateral IRI. mATG effectively depleted circulating T cells but had less effect on kidney-infiltrating T cells. There was no difference in serum creatinine levels between groups in each study. Scoring of renal tubular damage and regenerating tubules revealed no difference between groups. The percentage of CD3+CD4-CD8- double-negative (DN) T cells, which were reported to contribute to the pathogenesis of lupus nephritis, increased and the percentages of regulatory T cells and NK cells decreased in the post-ischemic kidneys of mATG treated mice. mATG did not alter the expression of pro-inflammatory cytokines such as IFN-γ or anti-inflammatory cytokines such as IL-10 in post-ischemic kidneys. mATG treatment, whether initiated before ischemia or immediately after reperfusion, had minimal effects on renal injury following warm IRI in mice.

Original languageEnglish
Pages (from-to)44-54
Number of pages11
JournalTransplant Immunology
Volume22
Issue number1-2
DOIs
Publication statusPublished - 2009 Jan 1
Externally publishedYes

Fingerprint

Warm Ischemia
Antilymphocyte Serum
Reperfusion Injury
Kidney
Delayed Graft Function
T-Lymphocytes
Cytokines
Lupus Nephritis
Regulatory T-Lymphocytes
Natural Killer Cells
Interleukin-10
Reperfusion
Allografts
Immunoglobulins
Creatinine
Appointments and Schedules
Anti-Inflammatory Agents
Ischemia
Rabbits

Keywords

  • Anti-thymocyte globulin
  • Immune mechanisms
  • Ischemia-reperfusion injury

ASJC Scopus subject areas

  • Immunology
  • Immunology and Allergy
  • Transplantation

Cite this

The effect of murine anti-thymocyte globulin on experimental kidney warm ischemia-reperfusion injury in mice. / Jang, Hye Ryoun; Gandolfo, Maria Teresa; Ko, Gang Jee; Racusen, Lorraine; Rabb, Hamid.

In: Transplant Immunology, Vol. 22, No. 1-2, 01.01.2009, p. 44-54.

Research output: Contribution to journalArticle

Jang, Hye Ryoun ; Gandolfo, Maria Teresa ; Ko, Gang Jee ; Racusen, Lorraine ; Rabb, Hamid. / The effect of murine anti-thymocyte globulin on experimental kidney warm ischemia-reperfusion injury in mice. In: Transplant Immunology. 2009 ; Vol. 22, No. 1-2. pp. 44-54.
@article{aba05ef923c54dccb715ba785a9452a0,
title = "The effect of murine anti-thymocyte globulin on experimental kidney warm ischemia-reperfusion injury in mice",
abstract = "Kidney ischemia-reperfusion injury (IRI) is an important contributor to delayed graft function (DGF) and poor outcome of allografts. Small clinical studies suggest a beneficial role for human anti-thymocyte globulin (ATG) in DGF. We investigated the short-term effect of mouse anti-thymocyte globulin (mATG) on kidney warm IRI in mice. We administered either mATG, rabbit immunoglobulin (RIgG), or saline with different dosing schedules in three different IRI models: 30 min bilateral, 60 min bilateral, and 45 min unilateral IRI. mATG effectively depleted circulating T cells but had less effect on kidney-infiltrating T cells. There was no difference in serum creatinine levels between groups in each study. Scoring of renal tubular damage and regenerating tubules revealed no difference between groups. The percentage of CD3+CD4-CD8- double-negative (DN) T cells, which were reported to contribute to the pathogenesis of lupus nephritis, increased and the percentages of regulatory T cells and NK cells decreased in the post-ischemic kidneys of mATG treated mice. mATG did not alter the expression of pro-inflammatory cytokines such as IFN-γ or anti-inflammatory cytokines such as IL-10 in post-ischemic kidneys. mATG treatment, whether initiated before ischemia or immediately after reperfusion, had minimal effects on renal injury following warm IRI in mice.",
keywords = "Anti-thymocyte globulin, Immune mechanisms, Ischemia-reperfusion injury",
author = "Jang, {Hye Ryoun} and Gandolfo, {Maria Teresa} and Ko, {Gang Jee} and Lorraine Racusen and Hamid Rabb",
year = "2009",
month = "1",
day = "1",
doi = "10.1016/j.trim.2009.08.001",
language = "English",
volume = "22",
pages = "44--54",
journal = "Transplant Immunology",
issn = "0966-3274",
publisher = "Elsevier",
number = "1-2",

}

TY - JOUR

T1 - The effect of murine anti-thymocyte globulin on experimental kidney warm ischemia-reperfusion injury in mice

AU - Jang, Hye Ryoun

AU - Gandolfo, Maria Teresa

AU - Ko, Gang Jee

AU - Racusen, Lorraine

AU - Rabb, Hamid

PY - 2009/1/1

Y1 - 2009/1/1

N2 - Kidney ischemia-reperfusion injury (IRI) is an important contributor to delayed graft function (DGF) and poor outcome of allografts. Small clinical studies suggest a beneficial role for human anti-thymocyte globulin (ATG) in DGF. We investigated the short-term effect of mouse anti-thymocyte globulin (mATG) on kidney warm IRI in mice. We administered either mATG, rabbit immunoglobulin (RIgG), or saline with different dosing schedules in three different IRI models: 30 min bilateral, 60 min bilateral, and 45 min unilateral IRI. mATG effectively depleted circulating T cells but had less effect on kidney-infiltrating T cells. There was no difference in serum creatinine levels between groups in each study. Scoring of renal tubular damage and regenerating tubules revealed no difference between groups. The percentage of CD3+CD4-CD8- double-negative (DN) T cells, which were reported to contribute to the pathogenesis of lupus nephritis, increased and the percentages of regulatory T cells and NK cells decreased in the post-ischemic kidneys of mATG treated mice. mATG did not alter the expression of pro-inflammatory cytokines such as IFN-γ or anti-inflammatory cytokines such as IL-10 in post-ischemic kidneys. mATG treatment, whether initiated before ischemia or immediately after reperfusion, had minimal effects on renal injury following warm IRI in mice.

AB - Kidney ischemia-reperfusion injury (IRI) is an important contributor to delayed graft function (DGF) and poor outcome of allografts. Small clinical studies suggest a beneficial role for human anti-thymocyte globulin (ATG) in DGF. We investigated the short-term effect of mouse anti-thymocyte globulin (mATG) on kidney warm IRI in mice. We administered either mATG, rabbit immunoglobulin (RIgG), or saline with different dosing schedules in three different IRI models: 30 min bilateral, 60 min bilateral, and 45 min unilateral IRI. mATG effectively depleted circulating T cells but had less effect on kidney-infiltrating T cells. There was no difference in serum creatinine levels between groups in each study. Scoring of renal tubular damage and regenerating tubules revealed no difference between groups. The percentage of CD3+CD4-CD8- double-negative (DN) T cells, which were reported to contribute to the pathogenesis of lupus nephritis, increased and the percentages of regulatory T cells and NK cells decreased in the post-ischemic kidneys of mATG treated mice. mATG did not alter the expression of pro-inflammatory cytokines such as IFN-γ or anti-inflammatory cytokines such as IL-10 in post-ischemic kidneys. mATG treatment, whether initiated before ischemia or immediately after reperfusion, had minimal effects on renal injury following warm IRI in mice.

KW - Anti-thymocyte globulin

KW - Immune mechanisms

KW - Ischemia-reperfusion injury

UR - http://www.scopus.com/inward/record.url?scp=70449525197&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=70449525197&partnerID=8YFLogxK

U2 - 10.1016/j.trim.2009.08.001

DO - 10.1016/j.trim.2009.08.001

M3 - Article

C2 - 19682579

AN - SCOPUS:70449525197

VL - 22

SP - 44

EP - 54

JO - Transplant Immunology

JF - Transplant Immunology

SN - 0966-3274

IS - 1-2

ER -